In the ever-evolving landscape of medical histopathology, the quest for efficiency, standardization, and cost-effectiveness has driven groundbreaking innovations. At the forefront of this revolution is the BxChip® technology by Lumea,…
Lumea, dedicated to advancing tissue standardization and digital pathology, solidified its position in the United States in the latest KLAS Research LEHI, UTAH, USA, February 8, 2024 /EINPresswire.com/ — Lumea,…
Patient care notwithstanding, is digital pathology actually better for individual pathologists than traditional pathology? Promoters of digital pathology claim that, in addition to various diagnostic advantages, the technology can be…
Lumea, a pioneer digital pathology company, will showcase its state-of-the-art solutions for prostate cancer at the upcoming 34th International Prostate Cancer Update in February. Event Details: The 34th International Prostate…
In the ever-evolving landscape of healthcare, breakthroughs in technology play a pivotal role in transforming patient outcomes. Lumea, a distinguished digital pathology company, is gearing up to showcase its cutting-edge…
*BxLink has not been approved by the FDA for digital primary diagnosis. Refer to CAP guidelines regarding the use of digital pathology technologies.
